Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries

EClinicalMedicine(2020)

引用 24|浏览5
暂无评分
摘要
Expertise-France and Agence Française de Développement.
更多
查看译文
关键词
Tuberculosis,Multidrug-resistance,Treatment outcome,Recurrence,Cohort studies,Proportional hazard models,Short regimen,Developing countries,Isoniazid,Fluoroquinolones
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要